Los Angeles Capital Management LLC Amicus Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

$24.2 Billion
Q4 2024

A detailed history of Los Angeles Capital Management LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 20,474 shares of FOLD stock, worth $188,156. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,474

Previous 20,474 -0.0%

Holding current value

$188,156

Previous $218,000 11.93%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$9.55 - $12.09 $61,922 - $78,391	6,484 Added 46.35%	20,474 $218,000
Q2 2024 Aug 05, 2024	SELL	$9.04 - $11.75 $943,504 - $1.23 Million	-104,370 Reduced 88.18%	13,990 $138,000
Q1 2024 Apr 05, 2024	BUY	$11.43 - $14.24 $1.2 Million - $1.5 Million	105,384 Added 812.15%	118,360 $1.39 Million
Q3 2023 Nov 06, 2023	BUY	$11.78 - $13.86 $152,857 - $179,847	12,976 New	12,976 $157,000
Q2 2021 Aug 05, 2021	SELL	$8.71 - $10.72 $667,029 - $820,959	-76,582 Reduced 64.35%	42,422 $409,000
Q1 2021 May 05, 2021	SELL	$9.2 - $23.86 $266,211 - $690,412	-28,936 Reduced 19.56%	119,004 $1.18 Million
Q4 2020 Feb 04, 2021	SELL	$13.47 - $24.89 $107,894 - $199,368	-8,010 Reduced 5.14%	147,940 $3.42 Million
Q3 2020 Nov 02, 2020	SELL	$12.89 - $15.89 $898,626 - $1.11 Million	-69,715 Reduced 30.89%	155,950 $2.2 Million
Q2 2020 Aug 05, 2020	BUY	$8.86 - $15.69 $9,054 - $16,035	1,022 Added 0.45%	225,665 $3.4 Million
Q1 2020 May 04, 2020	BUY	$6.63 - $11.16 $698,397 - $1.18 Million	105,339 Added 88.29%	224,643 $2.08 Million
Q4 2019 Feb 07, 2020	BUY	$7.48 - $10.75 $732,890 - $1.05 Million	97,980 Added 459.48%	119,304 $1.16 Million
Q3 2019 Nov 07, 2019	SELL	$8.02 - $13.25 $639,242 - $1.06 Million	-79,706 Reduced 78.89%	21,324 $171,000
Q2 2019 Jul 29, 2019	BUY	$10.96 - $14.4 $64,828 - $85,176	5,915 Added 6.22%	101,030 $1.26 Million
Q1 2019 Apr 25, 2019	BUY	$10.04 - $13.92 $660,130 - $915,240	65,750 Added 223.91%	95,115 $1.29 Million
Q4 2018 Feb 11, 2019	SELL	$8.38 - $13.44 $138,689 - $222,432	-16,550 Reduced 36.04%	29,365 $281,000
Q3 2018 Nov 05, 2018	SELL	$11.6 - $16.54 $21,228 - $30,268	-1,830 Reduced 3.83%	45,915 $555,000
Q2 2018 Jul 31, 2018	BUY	$13.13 - $17.09 $84,294 - $109,717	6,420 Added 15.54%	47,745 $746,000
Q1 2018 Apr 27, 2018	BUY	$13.76 - $17.12 $568,632 - $707,484	41,325 New	41,325 $622,000

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

311M

Call Options Held

467K

Put Options Held

515K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.58B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Amicus Therapeutics, Inc. Transaction History